Markets
Jefferies Upgrades Dr. Reddy's Stock: What the Margin Outlook Means for Traders
Jefferies has upgraded Dr. Reddy's Laboratories, flagging a materially improved margin trajectory as the key driver. The move repositions one of India's largest pharma exporters as a compelling risk-reward play heading into the final quarter of 2026.